A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII)

YILMAZ A., MİRİLİ C., BİLİCİ M., TEKİN S. B.

JOURNAL OF BUON, cilt.24, sa.5, ss.2127-2135, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 5
  • Basım Tarihi: 2019
  • Dergi Adı: JOURNAL OF BUON
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2127-2135
  • Anahtar Kelimeler: gastrointestinal stromal tumor (GIST), systemic immune inflammation index (SII), prognostic nutritional index (PNI), neutrophil-lympocyte ratio (NLR), PROGNOSTIC NUTRITIONAL INDEX, LYMPHOCYTE RATIO, CANCER, NEUTROPHIL, PATHOLOGY, RISK
  • Atatürk Üniversitesi Adresli: Evet

Özet

Purpose: Systemic inflammation and immune response are associated with tumors'prognosis. However, there is little information about inflammatory indexes in patients with gastrointestinal stromal tumor (GIST). In this study, we aimed to determine the prognostic significance of inflammation indexes such as neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII), prognostic nutritional index (PNI) and Glasgow prognostic score (GPS) in GIST patients.